ASK REDCHAT ANYTHING ABOUT BOLT BIOTHERAPEUTICS INC.
Bolt Biotherapeutics Inc. (NASDAQ: BOLT)
Listen to this Section
$4.64
-0.1200
(
-2.52% )
10.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| BDC-3042DetailsSolid tumor/s, Cancer |
Phase 1 |
| BDC-1001 +/- pertuzumabDetailsHER2-expressing cancers |
Failed |
Market Data
|
| Open |
$4.64 |
| Previous Close |
$4.76 |
| Volume |
10.0K |
| Market Cap |
$8.90M |
| Day Range |
$4.55 - $5.40 |
| 52 Week Range |
$3.91 - $7.35 |
| Shares Outstanding |
1.92M |
| Change % |
-2.52% |
| Net Change |
▼ -0.1200 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2021 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-2,191,821.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-12-13 |
Buy |
1829.00 |
Quinn William P. |
| 2023-12-01 |
Sale |
-22674.00 |
ENGLEMAN EDGAR |
| 2023-11-22 |
Sale |
-1707.00 |
Vivo Capital VIII, LLC |
| 2023-11-22 |
Sale |
-1707.00 |
ENGLEMAN EDGAR |
| 2023-11-20 |
Sale |
-7531.00 |
Vivo Capital VIII, LLC |
| 2023-11-20 |
Sale |
-7531.00 |
ENGLEMAN EDGAR |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 10-k |
Annual reports |
82 |
Mar 12, 2026 |
| 8-k |
8K-related |
12 |
Mar 12, 2026 |
| s-8 |
Registration statements |
16 |
Mar 12, 2026 |
| schedule |
Other |
2 |
Feb 26, 2026 |
| schedule |
Other |
2 |
Feb 17, 2026 |
| schedule |
Other |
1 |
Feb 13, 2026 |
| 4 |
Insider transactions |
1 |
Feb 04, 2026 |
| 4 |
Insider transactions |
1 |
Feb 04, 2026 |
| 4 |
Insider transactions |
1 |
Feb 04, 2026 |
| 4 |
Insider transactions |
1 |
Dec 16, 2025 |